Adult onset Still’s disease
pathogenesis
biomarkers
Rheumatology Biologics
Targeted therapy Registry
Date | Time | Room | Session Title | Lecture Title |
---|---|---|---|---|
May 18 | 08:00-09:00 | Room Room3 | Breakfast Symposium 6 [Samsung Bioepis] Anti-TNF-α Treatment | Treatment option (Adalimumab) for RA patients |
May 18 | 14:00-14:30 | Room Room2 | KCR-KCPCI Joint Symposium_Current Status and Advances of Major Pediatric Rheumatic Diseases | Advances in still's disease (systemic JIA, AOSD) |